ORALE CANNABINOIDFORMULIERUNGEN
European patent · EP3582750 · In force
Register entry
- Publication number
- EP3582750
- Application number
- EP18706562
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Feb 15, 2018
- Published
- Dec 25, 2019
- Granted
- Jul 26, 2023
- Protection ends at the latest
- Feb 14, 2038
- Next annual fee due
- Feb 28, 2027
- IPC classes
- A61K 9/08 (2006.01)A61K 47/10 (2017.01)A61K 47/14 (2017.01)A61K 47/22 (2006.01)A61K 47/26 (2006.01)A61K 47/44 (2017.01)
- Priority
- GB 201702613 17.02.2017
- PCT application
- PCT/GB2018/050404 15.02.2018
- PCT publication
- WO2018/150182 23.08.2018
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Mar 1, 2026
Change
Published in Swissreg on 01.03.2026
- Aug 8, 2025
Holder’s address changed
- Owner
- GW Research Limited, Sovereign House Vision Park, Chivers Way, Histon, Cambridge, Cambridgeshire CB24 9BZ, United Kingdom → Jazz Pharmaceuticals Research UK Limited, Building 730 Kent Science Park, Sittingbourne, Kent, ME9 8AG, United Kingdom
Published in Swissreg on 08.08.2025
- Mar 1, 2025
Change
Published in Swissreg on 01.03.2025
- Jun 5, 2024
Change
Published in Swissreg on 05.06.2024
- Mar 1, 2024
Change
Published in Swissreg on 01.03.2024
- Oct 12, 2023
Agent entered
- Representative
- HGF GmbH, OBC Suisse AG, Aeschengraben 29, 4051 Basel
Published in Swissreg on 12.10.2023
- Jul 26, 2023
Granted
Published in Swissreg on 26.07.2023
Parties
Inventor
WRIGHT, Stephen
Cambridge Cambridgeshire CB24 9BZ, GB
WILKHU, Jitinder
Cambridge Cambridgeshire CB24 9BZ, GB
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.